Erratum (DOI:10.1053/j.ajkd.2010.01.021);Balance of Profibrotic and Antifibroting Signaling in Nephrogenic Systemic Fibrosis Skin Lesions

American Journal of Kidney Diseases

Volumn 55, Issue 6, 2010, Pages 1040-1049

  Schieren, Gisela ^a   Gambichler, Thilo ^b   Skrygan, Marina ^b   Burkert, Björn ^b   Altmeyer, Peter ^b   Rump, Lars Christian ^a   Kreuter, Alexander ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

connective tissue growth factor (CTGF); dermis; hemodialysis; Nephrogenic systemic fibrosis; SMAD; systemic sclerosis; tissue inhibitor of metalloproteinase 1 (TIMP 1); transforming growth factor (TGF ); tumor necrosis factor (TNF )

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; MALE; NEPHROGENIC SYSTEMIC FIBROSIS; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN DEFECT;

EID: 77952552868     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.05.007     Document Type: Erratum

References (33)

1. Cowper S.E., Robin H.S., Steinberg S.M., Su L.D., Gupta S., and LeBoit P.E. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356 (2000) 1000-1001
2. Mendoza F.A., Artlett C.M., Sandorfi N., Latinis K., Piera-Velazquez S., and Jimenez S.A. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35 (2006) 238-249
3. Galan A., Cowper S.E., and Bucala R. Nephrogenic sistemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol 18 (2006) 614-617
4. High W.A., Ayers R.A., and Cowper S.E. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56 (2007) 710-712
5. Todd D.J., Kagan A., Chibnik L.B., and Kay J. Cutaneous changes of nephrogenic systemic fibrosis. Semin Arthritis Rheum 35 (2006) 328-349
6. Marckmann P. Nephrogenic systemic fibrosis: epidemiology update. Curr Opin Nephrol Hypertens 17 (2008) 315-319
7. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
8. Schieren G., Wirtz N., Altmeyer P., Rump L.C., Weiner S.M., and Kreuter A. Nephrogenic systemic fibrosis-a rapidly disabling disease with limited therapeutic options. J Am Acad Dermatol 61 5 (2009) 868-874
9. Ihn H. Autocrine TGF-β signaling in the pathogenesis of systemic sclerosis. J Dermatol Soc 49 (2008) 103-113
10. Pannu J., Nakerakanti S., Smith E., ten Dijke P., and Trojanowski M. Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem 282 14 (2007) 10405-10413
11. Bhattacharyya S., Chen S., Wu M., et al. Smad-independent transforming growth factor-β regulation of early growth response-1 and sustained expression in fibrosis. Implications for scleroderma. Am J Pathol 173 (2008) 1085-1099
12. Varga J. Scleroderma and Smads. Dysfunctional family culminating in fibrosis. Arthritis Rheum 46 7 (2006) 1703-1713
13. Li Y., Foster W., Deasy B.M., et al. Transforming-growth factor-β1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle. Am J Pathol 164 (2004) 1007-1019
14. Dong C., Zhu S., Wang T., et al. Deficient Smad 7 expression: a putative molecular defect in scleroderma. PNAS 99 6 (2002) 3908-3913
15. Leask A. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal 20 (2008) 1409-1414
16. Shi-Wen X., Leask A., and Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 19 (2008) 133-144
17. Jiménez S.A., Artlett C.M., Sandorfi N., et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50 (2004) 2660-2666
18. Kelly B., Petitt M., and Sanchez R. Neprhogenic systemic fibrosis is associated with transforming growth factor β and Smad without evidence of renin-angiotensin system involvement. J Am Acad Dermatol 58 (2008) 1025-1030
19. Kucher C., Xu X., Pasha T., and Elenitsas R. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J Cutan Pathol 32 (2005) 484-490
20. Gambichler T., Skrygan M., Tomi N.S., et al. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 147 (2008) 17-24
21. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25 (2001) 402-408
22. Breuckmann F., Freitag M., Rotterdam S., Stuecker M., Altmeyer P., and Kreuter A. Immunohistochemical investigations and introduction of new therapeutic strategies in scleromyxoedema: case report. BMC Dermatol 4 1 (2004) 12
23. Gambichler T., Birkner L., Stücker M., Otlinghaus N., Altmeyer P., and Kreuter A. Upregulation of transforming growthfactor-β3 and extracellular matrix proteins in acquired reactive perforating collagenosis. J Am Acad Dermatol 60 3 (2009) 463-469
24. McNeese C., Scroggins L., and Kelly B. The balance of metalloproteinases in nephrogenic systemic fibrosis [abstract]. J Cutan Pathol 36 1 (2009) 146A
25. Schieren G., Tokmak F., Lefringhausen L., et al. C-Reactive protein levels and clinical symptoms following gadolinium administration in hemodialysis patients. Am J Kidney Dis 51 (2008) 976-986
26. Wermuth P.J., Del Galdo F., and Jiménez S.A. Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents. Arthritis Rheum 60 (2009) 1508-1518
27. Kräuter A., Höxtermann S., Gambichler T., Tigges C., Hahn S.A., and Schieren G. Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis. Arch Dermatol 145 (2009) 1164-1169
28. Gambichler T., Kreuter A., Skrygan M., Burkert B., Altmeyer P., and Schieren G. Decorin is significantly overexpressed in nephrogenic systemic fibrosis. Am J Clin Pathol 132 (2009) 139-143
29. Yamaguchi Y., Mann D.M., and Rouslahti E. Negative regulation of transforming growth factor-beta by the proteoglykan decorin. Nature 19 (1990) 281-284
30. Reed C.C., and Iozzo R.V. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 19 (2002) 249-255
31. Richmond H., Zwerner J., Kim Y., and Fiorentino D. Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis. Arch Dermatol 143 8 (2007) 1025-1030
32. Lan H.Y. Smad 7 as a therapeutic agent for chronic kidney diseases. Front Biosci 13 (2008) 4984-4992
33. Cohen B.D. Premature aging in uremia. Mol Cell Biochem 298 (2007) 195-198